You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 13, 2026
Sale
Calculated transaction value
$729.64K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 12, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$550.1
Oct 12, 2026
First close after public filing
$540.03
Oct 14, 2026
Return after filing · so far
+10.3%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,329 shares @ $549.01
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000162
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$6.35M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 12, 2026 | $74.85K |
| United Therapeutics Corp UTHR | Sale | Oct 12, 2026 | $234.6K |
| United Therapeutics Corp UTHR Current | Sale | Oct 12, 2026 | $729.64K |
| United Therapeutics Corp UTHR | Sale | Oct 12, 2026 | $1.45M |
| United Therapeutics Corp UTHR | Exercise | Oct 12, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 12, 2026 | $1.41M |
| United Therapeutics Corp UTHR | Sale | Oct 12, 2026 | $1.02M |
| United Therapeutics Corp UTHR | Sale | Oct 12, 2026 | $308.53K |
| United Therapeutics Corp UTHR | Exercise | Oct 12, 2026 | $0 |